Free for academic non-profit institutions. Other users need a Commercial license
CDK12 (Cyclin Dependent Kinase 12) is a Protein Coding gene. Diseases associated with CDK12 include Corneal Endothelial Dystrophy and Gastric Cancer. Among its related pathways are Gene Expression and HIV Transcription Elongation. Gene Ontology (GO) annotations related to this gene include transferase activity, transferring phosphorus-containing groups and protein tyrosine kinase activity. An important paralog of this gene is CDK13.
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0000166 | nucleotide binding | IEA | -- |
GO:0004672 | protein kinase activity | IEA,IDA | 11683387 |
GO:0004674 | protein serine/threonine kinase activity | IEA | -- |
GO:0004693 | cyclin-dependent protein serine/threonine kinase activity | IBA | 21873635 |
GO:0005515 | protein binding | IPI | 12841360 |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0000307 | cyclin-dependent protein kinase holoenzyme complex | IBA | 21873635 |
GO:0000790 | nuclear chromatin | IBA | 21873635 |
GO:0002944 | cyclin K-CDK12 complex | IPI | 22012619 |
GO:0005634 | nucleus | IBA | 21873635 |
GO:0005654 | nucleoplasm | TAS | -- |
SuperPathway | Contained pathways | ||
---|---|---|---|
1 | Gene Expression |
.48
|
|
2 | DNA Damage | ||
3 | HIV Transcription Elongation | ||
4 | Regulation of TP53 Activity |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0006368 | transcription elongation from RNA polymerase II promoter | IBA | 21873635 |
GO:0006397 | mRNA processing | IEA | -- |
GO:0006468 | protein phosphorylation | IEA,IBA | 21873635 |
GO:0008380 | RNA splicing | ISS | -- |
GO:0016310 | phosphorylation | IEA | -- |
Name | Status | Disease Links | Group | Role | Mechanism of Action | Clinical Trials |
---|---|---|---|---|---|---|
Benzocaine | Approved, Investigational | Pharma | 3109 | |||
Ipilimumab | Approved | Pharma | Therapeutic Antibodies, Immunotherapies, Immunomodulatory agents | 676 | ||
nivolumab | Approved | Pharma | Therapeutic Antibodies, Immunotherapies | 1165 | ||
Pembrolizumab | Approved | Pharma | 1266 | |||
Rucaparib | Approved, Investigational | Pharma | PARP inhibitor, PARP Inhibitors, Other | 57 |
Name | Synonyms | Role | CAS Number | PubChem IDs | PubMed IDs | |
---|---|---|---|---|---|---|
ADP |
|
Agonist, Full agonist, Partial agonist, Gating inhibitor, Antagonist | 58-64-0 |
|
ExUns: | 1a | · | 1b | ^ | 2 | ^ | 3 | ^ | 4 | ^ | 5 | ^ | 6 | ^ | 7 | ^ | 8 | ^ | 9 | ^ | 10 | ^ | 11 | ^ | 12 | ^ | 13 | ^ | 14a | · | 14b |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SP1: | - | ||||||||||||||||||||||||||||||
SP2: |
This gene was present in the common ancestor of eukaryotes.
Organism | Taxonomy | Gene | Similarity | Type | Details |
---|---|---|---|---|---|
Chimpanzee (Pan troglodytes) |
Mammalia | CDK12 30 31 |
|
OneToOne | |
Dog (Canis familiaris) |
Mammalia | CDK12 30 31 |
|
OneToOne | |
Cow (Bos Taurus) |
Mammalia | CDK12 30 31 |
|
OneToOne | |
Rat (Rattus norvegicus) |
Mammalia | Cdk12 30 |
|
||
Mouse (Mus musculus) |
Mammalia | Cdk12 30 17 31 |
|
OneToOne | |
Oppossum (Monodelphis domestica) |
Mammalia | -- 31 |
|
OneToMany | |
-- 31 |
|
OneToMany | |||
Platypus (Ornithorhynchus anatinus) |
Mammalia | CDK12 31 |
|
OneToOne | |
Chicken (Gallus gallus) |
Aves | CDK12 30 31 |
|
OneToOne | |
Lizard (Anolis carolinensis) |
Reptilia | -- 31 |
|
OneToMany | |
-- 31 |
|
OneToMany | |||
Tropical Clawed Frog (Silurana tropicalis) |
Amphibia | cdk12 30 |
|
||
Str.18694 30 |
|
||||
African clawed frog (Xenopus laevis) |
Amphibia | Xl.15324 30 |
|
||
Zebrafish (Danio rerio) |
Actinopterygii | cdk12 31 |
|
ManyToMany | |
Fruit Fly (Drosophila melanogaster) |
Insecta | Cdk12 31 |
|
OneToMany | |
Worm (Caenorhabditis elegans) |
Secernentea | cdk-12 31 |
|
OneToMany | |
Baker's yeast (Saccharomyces cerevisiae) |
Saccharomycetes | CTK1 31 |
|
OneToMany | |
Wheat (Triticum aestivum) |
Liliopsida | Ta.21132 30 |
|
||
Sea Squirt (Ciona savignyi) |
Ascidiacea | CSA.10559 31 |
|
OneToMany |
SNP ID | Clinical significance and condition | Chr 17 pos | Variation | AA Info | Type |
---|---|---|---|---|---|
rs1131692238 | Likely Pathogenic: Lung adenocarcinoma | 39,509,731(+) | G/T | MISSENSE_VARIANT | |
rs141353560 | Not Provided: not specified | 39,490,613(+) | G/A | MISSENSE_VARIANT | |
rs142347393 | Not Provided: not specified | 39,530,840(+) | C/T | MISSENSE_VARIANT | |
rs144501352 | Not Provided: not specified | 39,471,687(+) | A/G | MISSENSE_VARIANT | |
rs186043011 | Not Provided: not specified | 39,531,224(+) | G/T | MISSENSE_VARIANT |
Variant ID | Type | Subtype | PubMed ID |
---|---|---|---|
dgv50n6 | CNV | deletion | 16902084 |
esv1352810 | CNV | deletion | 17803354 |
esv2263528 | CNV | deletion | 18987734 |
esv2715901 | CNV | deletion | 23290073 |
esv2715902 | CNV | deletion | 23290073 |
esv2715903 | CNV | deletion | 23290073 |
esv3554404 | CNV | deletion | 23714750 |
nsv1063848 | CNV | gain | 25217958 |
nsv1116009 | CNV | deletion | 24896259 |
nsv1127568 | CNV | deletion | 24896259 |
nsv1134648 | CNV | deletion | 24896259 |
nsv1146669 | OTHER | inversion | 26484159 |
nsv1147003 | CNV | deletion | 26484159 |
nsv1152691 | CNV | deletion | 26484159 |
nsv819586 | CNV | gain | 19587683 |
nsv827985 | CNV | loss | 20364138 |
nsv955421 | CNV | deletion | 24416366 |
Disorder | Aliases | PubMed IDs |
---|---|---|
corneal endothelial dystrophy |
|
|
gastric cancer |
|
|
ovary adenocarcinoma |
|
|
ovarian serous cystadenocarcinoma |
|
|
suppression of tumorigenicity 12 |
|
|